Cardiac Sciences Program, University of Manitoba, Winnipeg, Manitoba, Canada.
Cardiac Sciences Program, University of Manitoba, Winnipeg, Manitoba, Canada.
Am J Cardiol. 2020 Jun 15;125(12):1770-1773. doi: 10.1016/j.amjcard.2020.03.020. Epub 2020 Apr 2.
With the routine use of primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), the rate of short-term complications is low and the optimal length-of-stay in the coronary care unit (CCU) following reperfusion is unknown. We hypothesized that the rate of complications would not differ between two groups of stable patients admitted to the CCU following primary-PCI for STEMI: (1) those for whom a minimum 24-hour stay was enforced (≥24 hour Standard Stay) and (2) those with no minimum length-of-stay (Physician-guided Stay). Data were collected retrospectively. We performed a regression analysis to determine predictors of the primary endpoint (a composite of in-hospital death, re-infarction and/or re-intervention, heart failure requiring intravenous diuretics, cardiac arrest, central nervous system and/or peripheral embolization, bleeding requiring transfusion, arrhythmia resulting in initiation of a class I or III antiarrhythmic drug, initiation of assisted ventilation, requirement for vasopressors or inotropes, or transfer to intensive care). A total of 242 patients were included in the analysis. The rate of the primary endpoint was 8% in the physician-guided stay group and 16% in the standard ≥24 hour stay group (p = 0.06). The most common complication in both groups was heart failure requiring diuretics (42%), which was predicted by the left ventricular end diastolic pressure on catheterization (area under the Receiver-Operator Curve of 0.75). In conclusion, Patients who are stable following primary PCI for STEMI have a low rate of complications. Stable STEMI patients do not appear to benefit from a mandatory ≥24 hours stay in the CCU.
随着经皮冠状动脉介入治疗(PCI)在 ST 段抬高型心肌梗死(STEMI)中的常规应用,短期并发症的发生率较低,再灌注后在冠心病监护病房(CCU)的最佳住院时间尚不清楚。我们假设,在接受直接 PCI 治疗 STEMI 后入住 CCU 的两组稳定患者中,并发症发生率没有差异:(1)强制性 24 小时住院(≥24 小时标准住院);(2)无最短住院时间(医生指导住院)。数据是回顾性收集的。我们进行了回归分析,以确定主要终点(住院期间死亡、再梗死和/或再介入、需要静脉利尿剂的心力衰竭、心脏骤停、中枢神经系统和/或外周栓塞、需要输血的出血、导致使用 I 类或 III 类抗心律失常药物的心律失常、开始辅助通气、需要加压素或正性肌力药物或转至重症监护病房)的预测因素。共有 242 例患者纳入分析。在医生指导的住院组中,主要终点的发生率为 8%,在标准的≥24 小时住院组中为 16%(p=0.06)。在这两组中最常见的并发症是需要利尿剂的心力衰竭(42%),这可以通过导管插入术的左心室舒张末期压来预测(接收者操作特征曲线下面积为 0.75)。总之,直接 PCI 治疗 STEMI 后稳定的患者并发症发生率较低。稳定的 STEMI 患者似乎不需要强制性在 CCU 住院≥24 小时。